baber/WOPTO huggingface dataset:
Patent CA-2402373-A1 (CA)
Title: Tyre tread pattern
Inventor: MERINO LOPEZ JOSE
IPC: B60C11/11
Filed: 2001-02-09
Abstract: A tire tread comprising grooves defining motifs in relief, at least one of these motifs being provided with first and second incisions, said incisions each being defined by two main lateral surfaces connected by an end surface, each of the first incisions opening on to the running surface of the tread when new and extending at most as far as the depth, and each of the second incisions extends at least as far as the depth. The tread is characterized in that the bottom surfaces of the first incisions and the apex surfaces of the second incisions are functionally arranged such that, whatever the level of wear the length of the ridges on the running surface is at least equal to 75% of the length of the ridges when new.
Patent CA-2402839-A1 (CA)
Inventor: GENTZ REINER L
IPC: C07K14/705
Filed: 1999-07-02
Abstract: The present invention relates to novel galectin 11 proteins which are members of the galectin superfamily. In particular, isolated nucleic acid molecules are provided encoding the human galectin 11 proteins.  Galectin 11 polypeptide are also provided as are vector, host cells and recombinant method for producing the same. The invention further relates to screening methods for identifying agonists and antagonists of galectin 11 activity. Also provided are diagnostic and therapeutic methods.
Patent CA-2403105-A1 (CA)
Inventor: KHRIMIAN ASHOT
IPC: C07C41/58
Filed: 2001-03-15
Abstract: La présente invention concerne un procédé amélioré de production d'éther de fluorométhyl 2,2,2-trifluoro-1-(trifluorométhyl)éthyle (ou, sevoflurane), consistant à mettre à réagir 1,1,1,3,3,3-hexafluoro-2-propanole avec du formaldéhyde et du fluorure d'hydrogène, soit A) dans des conditions de distillation, soit B) en présence/addition ultérieure d'un solvant capable d'extraire le sevoflurane de manière sélective.
Patent CA-2405074-A1 (CA)
Title: Method and apparatus for internet-based telephone access to prepaid card and pin systems
Inventor: LIU TONG
IPC: H04M15/00
Filed: 2001-03-30
Abstract: A method of providing a pre-paid telephone calling card services to a callin g party initiating a voice-based connection to a called party telephone using an internet-based IP Phone process running on a personal computer. The method comprises initiating an A-leg connection between the IP Phone process and an  Internet Gateway utilizing a computer network connecting the personal comput er and the Internet Gateway (402), establishing a telephone connection between the internet gateway and a SCP (step 403). Once this connection is established, the SCP transmits a request to the calling party through the IP  Phone process to provide account and call information (step 404). The callin g party responds with the requested account and call information using the IP Phone process (step 405). The Internet Gateway then transmits the informatio n to the SCP using DTMF tones (step 406). The SCP responds by transmitting an account query from the SCP to verify account and balance information for the  calling party (step 407). If the account data is successfully verified, B-le g connections are connected in order to establish the voice-based connection between the calling party and the called party (step 408).
Patent CA-2407165-A1 (CA)
Inventor: LEE KYUNG-TAE
IPC: B29C45/27
Filed: 2002-10-09
Abstract: According to the present invention, a manifold mounting arrangement is provided wherein a leg manifold is securely mounted midway along its length rather than at its spree bushing and whereby thermally induced length changes are accommodated outwardly from its centre. Additionally, a first end of the leg manifold is clampingly secured between a spree housing and a manifold insulator to avoid movement of the first end toward the spree upon a spree break portion of the injection moulding cycle.
Patent CA-2408835-A1 (CA)
Inventor: DUMAS DAVID P
IPC: C07K16/20
Filed: 2001-05-10
Abstract: The invention provides a composition comprising a diverse population of reagent ligands attached to a solid support and a diverse populatin of reagent antibodies specifically bound to the reagent ligands. The ligands can be peptides, oligosaccharides, oligonucleotides, or organic molecules. The invention additionally provides methods of determining an epitope in a sample contacting a composition comprising a diverse population of ligands attached to a solid support and a diverse population of antibodies specifically bound to each of the ligands with a sample; and detecting the antibodies bound to the diverse population of ligands. The invention further provides methods of diagnosing a disease, identifying a potential therapeutic agent, and mapping accessible epitopes of a polypeptide using invention compositions.
Patent CA-2413980-A1 (CA)
Title: Video slice and active region based dual partial encryption
Inventor: CANDELORE BRANT L
IPC: H04N7/167
Filed: 2002-12-10
Abstract: A selective encryption encoder and method of dual selective encryption. The selective encryption encoder has a packet identifier that identifies packets of at least one specified packet type, the at least one specified packet type being any of a plurality of packet types including packets containing a video slice headers or packets carrying data appearing in an active area of the image. A packet duplicator duplicates the identified packets to produce first and second sets of the identified packets. The packets are sent to and from a primary encryption encoder to encrypt the first set of identified packets under a first encryption method. A secondary encrypter encrypts the second set of identified packets under a second encryption method.
Patent CA-2414884-A1 (CA)
Title: Immunisation contre une infection par chlamydia pneumoniae
Inventor: GRANDI GUIDO
IPC: A61K38/00
Filed: 2001-07-03
Abstract: La séquence génomique publiée de <i>Chlamydia pneumoniae</i> présente plus de 1000 protéines possibles codées, mais n'indique pas elle-même les protéines pouvant être utilisées comme antigènes pour une immunisation, une vaccination ou un diagnostic. Cette difficulté est surmontée par l'invention qui fournit un certain nombre de séquences protéiniques de <i>C. pneumoniae</i> appropriées pour développer et produire des vaccins et/ou pour établir un diagnostic.
Patent CA-2416154-A1 (CA)
Title: Rechargeable spinal cord stimulator system
Inventor: MEADOWS PAUL
IPC: A61N1/36
Filed: 2000-07-26
Abstract: A spinal cord stimulation (SCS) system includes implantable components (10), external components (20) and surgical tools and aids (30). The implantable components includes an implantable pulse generator (100), or IPG, having a rechargeable battery. The IPG (100) is connected to an electrode array (110) having at least sixteen electrodes. An extension lead (120) may be used, as required, to connect the IPG to the electrode array. The rechargeable battery is recharged using non-invasive means. The external components (20) include a hand held programmer (202), a clinician programmer (204), and an external trial stimulator (140). The trial stimulator may connect directly with the implantable electrode array (110) via a percutaneous extension lead (132), communications with the IPG are established via an RF link established between the pulse generator and an external hand held programmer (202), or HHP.Similar cirucitry may control the applied stimulation pulses as a burst of pulses ends in order to gradually ramp down the amplitude. Other processing circuitry allows electrode impedance measurements to be regularly made.
Patent CA-2418370-A1 (CA)
Title: Modified yeasts and uses thereof, in particular for producing steroid derivatives
Inventor: DUMAS BRUNO
IPC: C12R1/865
Filed: 2001-07-24
Abstract: The invention concerns novel yeast strains, methods and genetic constructs for preparing them, and their use for synthesising or modifying steroid compounds. More particularly, the invention concerns strains having reduced 20.alpha.-HSD activity, in particular by modification of the GCY1 and/or YPR1 genes. The inventive yeast strains enable to improve the efficacy of synthesis or to increase selectivity or yields of the process, as well as the quality of the final product. The inventive strains, methods and compounds are useful for researching, developing and producing products with therapeutic or prophylactic activity, in a human or an animal, in particular steroid derivatives.
Patent CA-2420280-A1 (CA)
Title: Compact sewage secondary treatment system
Inventor: BUTTS NICHOLAS E
IPC: C02F3/30
Filed: 2001-08-28
Abstract: A treatment tank (1) for the secondary treatment of sewage, for providing the processes of aeration, nitrification and denitrification, in a single structure, for which a single, small horsepower, effluent pump (26) is the only moving part. In the treatment tank (1), the sewage is subjected to two separate biological treatments, in two separate chambers under different conditions. One biological treatment is carried out under anoxic conditions in a pipe coil (3). Anoxic conditions are ensured by keeping the pipe coil (3) full at all times; the pipe coil axis is vertical, and the pump forces the fluid flow upwardly through the coil. The second biological treatment is carried out under aerobic conditions in a trickle down filter (8). In a preferred embodiment, a welded pipe coil (3) used both to provide the anoxic conditions and to provide a tank containing the trickle down filter (8). The secondary treatment tank is generally used as part of a raw sewage treatment system, which will include a recycle loop which ensures that even when there is no raw sewage entering the system there is always a flow of liquid through the treatment tank.
Patent CA-2424453-A1 (CA)
Title: Label printer applicator unwind sensor
Inventor: DODS STEVEN M
IPC: B65C9/18
Filed: 2003-03-31
Abstract: A label applicator of the type for separating labels from a continuous carrier strip and applying the labels to an object positioned at the applicator, which applicator includes a supply roll and a rewind roll configured to move the strip through the applicator, a tamp pad for applying the labels to the object, and an unwind sensor. The unwind sensor includes a supply disk positioned coaxially on the supply roll. The supply disk has a plurality of equally spaced openings therein. A sensor is configured for sensing the passing of the supply disk openings. A counter counts the openings passing the sensor. The applicator includes means for determining a level of labels remaining on the supply roll.
Patent CA-2426084-A1 (CA)
Inventor: MADSEN SOEREN MICHAEL
IPC: C12N1/00
Filed: 2001-10-19
Abstract: Fed-batch or continuous process for producing heterologous peptides, polypeptides or proteins in lactic acid bacteria, comprising the steps of (i) constructing a recombinant lactic acid bacterium comprising a nucleotide sequence coding for the heterologous peptide, polypeptide or protein, and appropriate regulatory nucleotide sequences such as regulatable promoters and signal peptides to control the expression of the coding sequence and the secretion of gene product, (ii) cultivating the recombinant bacterium under fed-batch or continuous cultivation conditions to express the gene, and (iii) harvesting the recombinant bacterium or the gene product. Preferably, the cultivation medium is a chemically defined or synthetic medium optionally supplemented with yeast extract.
Patent CA-2427952-A1 (CA)
Title: Dna expression vectors
Inventor: ELLIS JONATHAN HENRY
IPC: A61P25/28
Filed: 2001-11-02
Abstract: The invention relates to DNA vectors containing a transcription regulatory sequence derived from Human Cytomegalovirus major immediate early gene that includes exon 1, but not intron A. Vectors, host cells, pharmaceutical and vaccine compositions comprising such host cells and vectors are contemplated.
Patent CA-2428424-A1 (CA)
Inventor: PRESTON LORIE M
IPC: G06F17/40
Filed: 2003-05-09
Abstract: A computerized system and method for conducting a survey of the promotional activities of sales representatives for specific pharmaceuticals of the various pharmaceutical companies. A single panel of physicians is provided to collect data regarding both (1) the promotional activities of the sales representatives whom they have encountered, and (2) the diagnosis and treatment of their patients. The data is provided into a database for analysis to evaluate any cause and effect relationship between the promotional activities of the sales representatives and the pharmaceuticals prescribed by them to their patients. Primary market research studies can also be conducted by select appropriate physicians from the panel to whore a survey is to be administered and by analyzing their answers in the context of the data in the database.
Patent CA-2430096-A1 (CA)
Title: Cyclone-type dust collecting apparatus for a vacuum cleaner
Inventor: OH JANG-KEUN
IPC: A47L9/16
Filed: 2003-05-27
Abstract: Disclosed is a cyclone-type dust collecting apparatus for a vacuum cleaner which is disposed in a dust collecting chamber connected with an air inlet path and an air discharge path of the cleaner for separating dusts and contaminants from air drawn in through a suction brush and then the air inlet path by a centrifugal force, the cyclone-dust collecting apparatus comprising a cylindrical cyclone body having an air inlet port and air discharge port respectively corresponding to the air inlet path and the air discharge path and fixed in an upper portion of the dust collecting chamber, a dirt-collecting receptacle removably disposed in a lower side of the cyclone body for collecting dusts and contaminants separated in the cyclone body by a centrifugal force, a filter assembly disposed in a lower part of the cyclone body and having a rotation filter rotated by air flow moving from the dirt-collecting receptacle to the air discharge port and preventing contaminants from flowing back, and a dusting member for automatically removing dusts on the rotation filter.
Patent CA-2431011-A1 (CA)
Title: Compositions and methods of use for extracts of magnoliaceae plants
Inventor: GARRISON ROBERT JR
IPC: A61K36/575
Filed: 2001-12-03
Abstract: The invention relates to compositions and methods for preventing, treating, or managing sleeplessness, restlessness, weight gain including weight gain due to stress or lack of sleep, or all three comprising the administration of a prophylactically and therapeutically effective amount of Magnoliaceae plant or extracts thereof to a mammal in need of such therapy. Preferably the mammal is human and the composition have comprise at least two compounds selected from  magnolol, honokiol, and magnoflorine. Alternatively, the compositions may al so comprise about 2% honokiol by weight of the composition.
Patent CA-2432518-A1 (CA)
Title: Treatment of inoperable tumors by stereotactic injection of microspheres
Inventor: BENOIT JEAN-PIERRE
IPC: A61K9/16
Filed: 2001-12-21
Abstract: Use of biodegradable microspheres releasing an anticancer agent for the manufacture of a medicament for the use in the treatment in humans of inoperable tumors, wherein biodegradable microspheres are administered by stereotactic injection directly into the tumor, into the peritumoral area or  at the same time into the tumor and the peritumoral area.
Patent CA-2433979-A1 (CA)
Title: Sterilization with flow through container
Inventor: MORRISON TODD
IPC: A61L2/20
Filed: 2003-06-27
Abstract: A chemical vapor sterilization process is enhanced by flowing a portion of the sterilant vapor through an instrument container using a normal portion of the exhaust process. Preferably, an exhaust conduit which draws a vacuum on a sterilization chamber is oriented so that the container is adjacent an inlet to the conduit.
Patent CA-2434046-A1 (CA)
Inventor: RAAD ISSAM
IPC: G01N33/50
Filed: 2002-01-11
Abstract: La présente invention a trait à un ajustement de dosage et à un ajustement de la fréquence d'administration des antibiotiques qui sont excrétés, en majeur partie, par les voies biliaires à partir des examens des fonctions hépatiques, dans le but de diminuer les effets secondaires provoqués par l'antibiotique.
Patent CA-2434416-A1 (CA)
Title: Non-crystalline saliva-soluble coatings for elastomeric monofilament dental tapes
Inventor: BROWN DALE G
IPC: A61C15/04
Filed: 2001-08-23
Abstract: An improved dental tape treated with a substantive coating containing a crystal control substance, wherein said coating is: saliva soluble, substantially crystal-free, with a flaking value of less than about 20 and a  release value of about 100.
Patent CA-2435772-A1 (CA)
Title: Procede thermographique
Inventor: SANDVOSS ROLF
IPC: G01N25/72
Filed: 2002-01-24
Abstract: Procédé et dispositif (1) de contrôle de matériaux par détection et représentation imagée de différences de température au-dessus d'une valeur de seuil sur des surfaces d'objets à contrôler (8). A l'aide d'une caméra destinée à la détection et à la représentation imagée des différences de température au-dessus d'une valeur de seuil, des températures d'éléments (22) d'objet situés à l'intérieur d'une zone de contrôle (14) de l'objet (8) à contrôler orientée vers la caméra sont détectées dans un premier temps. Ensuite, de la chaleur est amenée sur la zone de contrôle (14) à l'aide d'un faisceau laser (4) de manière telle que la température de la surface de l'objet (8) à contrôler augmente dans la zone de contrôle (14) du montant au moins de la valeur de seuil. Les éléments (22) d'objet sont représentés sous forme d'éléments d'image de sorte que les différences de température au-dessus de la valeur de seuil entre les éléments (22) d'objet soient visibles. Le refroidissement de la zone de contrôle (14) est représentée à l'aide des éléments (20) d'image.
Patent CA-2437372-A1 (CA)
Inventor: KERR JOHN ELGIN
IPC: A61K47/10
Filed: 2002-02-01
Abstract: A method of manufacturing an itraconazole oral dosage from that is substantially free of residual methylene chloride comprises the steps of: (a) providing a working solution comprising an alcohol, a strong acid (preferably an inorganic acid or organic sulphonic acid), itraconazole, a water-soluble polymer, and water, with the itraconazole and the strong acid preferably present in the working solution in a ratio of 1 Mole itraconazole to 1-3 Moles acid; (b) providing particles formed from a pharmaceutically acceptable core material; (c) combining the working solution with the particles to produce itraconazole-coated particles; (d) drying the itraconazole-coated particles;  and(e) forming the dried itraconazole-coated particles into an itraconazole oral dosage form that is substantially free of residual methylene chloride.  The products of such methods and methods of use thereof are also disclosed.
Patent CA-2439936-A1 (CA)
Inventor: LEBRAS PHILIPPE
IPC: B65D71/00
Filed: 2002-03-04
Abstract: A wraparound carrier comprising a plurality of wall panels hingedly interconnected in series, wherein the wall panels include a pair of base wal l panels (12, 22) at the opposite end to the blank, and wherein one of the bas e wall panels (12) is connected to an adjacent wall panel (16) through a beam forming portion (14) that includes a bracket panel (34) hingedly connected t o the base wall panel (12) and a pair of support panels (38, 40) both connecte d to the bracket panel (34) and extending to said adjacent wall panel (16).</S DOAB>
Patent CA-2440518-A1 (CA)
Title: Method of producing n-substituted 2,6-dialkyl morpholines
Inventor: KUSCHE ANDREAS
IPC: C07D295/03
Filed: 2002-03-15
Abstract: The invention relates to a method of producing the N-substituted 2,6-dialkyl morpholines of general formula (I), wherein R1 and R2 independently represen t hydrogen, alkyl or cycloalkyl, or R1 and R2, together with the carbon atom t o which they are bound, represent a 5 to 14 membered carbocyclic compound, and R3 and R4 independently represent alkyl or cycloalkyl. The inventive substances are produced by reacting at least one carbonyl compound of genera l formula (II), wherein R1 and R2 are defined as above, with at least one morpholine of general formula (III), wherein R3 and R4 are defined as above, in the presence of hydrogen and at least one metal-containing catalyst, the active component of said catalyst substantially consisting of platinum group metals.
Patent CA-2443216-A1 (CA)
Title: Enantiomers of 1-[(4-chlorophenyl) phenylmethyl]-4-[(4-methylphenyl) sulfonyl] piperazine
Inventor: COSSEMENT ERIC
IPC: C07D295/073
Filed: 1994-03-11
Abstract: Levorotatory and dextrorotatory enantiomers of 1-[(4-chlorophenyl)phenylmethyl]-4-[(4-methylphenyl)sulfonyl]piperazine of the formula   their preparation and use for the preparation of substantially optically pure enantiomers of 1-[(4-chlorophenyl)phenylmethyl]piperazine, which are themselves valuable intermediate products for the preparation of optically active therapeutic compounds having a very high degree of optical purity.
Patent CA-2443333-A1 (CA)
Title: Systeme de remorquage pour vehicules vtt (srvtt)
Inventor: VILLENEUVE GILLES
IPC: B60D1/00
Filed: 2003-09-30
Abstract: Système simple et efficace pour augmenter la clairance nette du système de remorquage sur un véhicule V.T.T. par rapport au système existant qui est de 6 3/4 environ de clairance au sol. Ce nouveau système augmente la clairance nette de 14' a 17'. Permet le transfert de la barre de tirage de catégorie 3-2-1 du véhicul e (auto au camion au véhicule VTT et de ce fait augmente la capacité de charge et de façon sécuritaire.
Patent CA-2444512-A1 (CA)
Title: Dispositif et procede permettant de reduire le brouillage dans la propagation par trajets multiples
Inventor: HERRICK DAVID L
IPC: H04B1/10
Filed: 2002-04-30
Abstract: L'invention concerne un procédé et un dispositif permettant de réduire le brouillage dans la propagation par trajets multiples pour des signaux FM commerciaux utilisant des signaux secondaires SCA en format MAQ. Le procédé décrit dans cette invention consiste à suivre la série chronologique de mesures de phase d'un signal pilote pour stéréo reçu afin de déterminer la référence de phase adéquate pour la démodulation des signaux MAQ au milieu de la série chronologique. Les mesures de phase du signal pilote sont suivies durant une période de suivi prédéterminée. La mesure de phase est utilisée pour permettre la démodulation du signal MAQ. Les signaux secondaires SCA en format MAQ transmis sur une modulation de fréquence commerciale présentent un brouillage dans la propagation par trajets multiples et un brouillage de Doppler par déplacement de émetteur et du récepteur (pour poste mobile) réduits.
Patent CA-2444714-A1 (CA)
Title: Treatment for improving cellulose insulation
Inventor: ROOD LEONARD D
IPC: F16L59/02
Filed: 2003-10-08
Abstract: An improved fire retardant cellulose insulation with reduced density and reduced settling. A method consists of adding a material, the fibers of which have a positive electrostatic charge, is added onto a shredded newspaper base either before or after the addition of a pre-coat, consisting of a mixture of an inorganic, non-hygroscopic powder and an antistat. A fire retardant agent is then added and the materials are ground in a finish mill. The newspaper fibers become positioned at an angle to the paper pieces, increasing the distance between the paper pieces, thereby lowering the density of the cellulose. Increasing the amount of antistat will decrease settling at the expense of increasing density. Adding water to he insulation system will neutralize static electricity and minimize settling. Fibers such as ground cardboard, wood mulch, sawdust, fiberglass fibers and polyester fibers are examples of materials with electrostatically positively charged fibers.